SKU 27541

Prestige 5 + WNV 1ds

Merck - Prestige V + WNV is a killed vaccine that protects healthy horses 6 months of age or older against Equine Encephalomyelitis Eastern and Western, equine Herpesviruses(Rhino) EHV-1 and EHV-4, and Equine Influenza virus subtypes A1, A2 including KY93, KY02, and Tetanus Toxoid Plus West Nile.

Single dose w/syringe and needle

$58.45

Quantity

Description
Product Details

Prestige V + WNV is a killed vaccine that protects healthy horses 6 months of age or older against Equine Encephalomyelitis Eastern and Western, equine Herpesviruses(Rhino) EHV-1 and EHV-4, and Equine Influenza virus subtypes A1, A2 including KY93, KY02, and Tetanus Toxoid Plus West Nile. Prestige V + WNV with Havlogen Equine Vaccine is a combination of inactivated, concentrated, adjuvanted, tissue culture origin Equine Encephalomyelitis Viruses (Eastern and Western), Equine Herpesviruses (Rhino EHV-1 and EHV-4), Equine Influenza Viruses (EIV A/Equine 2/Kentucky/93 [H3N8] American, EIV A/Equine 2/Kentucky/02 [H3N8] American, EIV A/Equine 2/Newmarket/2/93 [H3N8] Eurasian), West Nile Virus - Flavivirus Chimera and Tetanus Toxoid. Killed virus.

FEATURES / BENEFITS

Prestige® V + WNV with Havlogen® is recommended for the prevention and aid of equine Eastern and Western Encephalomyelitis, EIV, EHV-1, EHV-4, West Nile Virus, and Tetanus

Formulated for maximum protection

Killed virus

Injectable vaccination

Made in the USA

SPECIFICATIONS

Single dose w/syringe and needle

INSTRUCTIONS

For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

Brand Merck

Reference 27541